Daniel Leventhal, MS, PhD

Daniel Leventhal, MS, PhD

Greater Boston
2K followers 500+ connections

Activity

Join now to see all activity

Experience

  • Generate Biomedicines, Inc. Graphic
  • -

    Cambridge, MA

  • -

    Lexington, Massachusetts

  • -

    Chicago, IL

  • -

    Chicago, IL

  • -

    Greater Chicago Area

  • -

    Chicago, IL

  • -

    Chicago, IL

  • -

    Chicago, IL

  • -

    Orlando, FL

  • -

    Orlando, FL

Education

  • University of Chicago Graphic

    The University of Chicago

    -

    Activities and Societies: University of Chicago Biotechnology Association, American Association of Immunologists, American Association of Cancer Research (Cancer Immunology Working Group)

  • -

    Program provides curriculum, clinical mentorship and training towards the translation of basic science into the clinic.

  • -

    Activities and Societies: Theta Chi Fraternity, Leads Scholars, Program for Undergraduate Research Experience (PURE), Summer Research Academy (SRA), Honors in the Major (HIM) Thesis, Research and Mentoring Program (RAMP), Student-Mentor Academic Research Teams (SMART), Student Undergraduate Research Council (SURC), Phi Alpha Delta Pre-Law Fraternity

  • -

Volunteer Experience

  • Participant

    Leads Scholars

    - 1 year 9 months

    Children

Publications

  • Shaping the repertoire of tumor-infiltrating effector and regulatory T cells.

    Immunological Reviews

    Many tumors express antigens that can be specifically or selectively recognized by T lymphocytes, suggesting that T-cell-mediated immunity may be harnessed for the immunotherapy of cancer. However, since tumors originate from normal cells and evolve within the context of self-tissues, the immune mechanisms that prevent the autoimmune attack of normal tissues function in parallel to restrict anti-tumor immunity. In particular, the purging of autoreactive T cells and the development of…

    Many tumors express antigens that can be specifically or selectively recognized by T lymphocytes, suggesting that T-cell-mediated immunity may be harnessed for the immunotherapy of cancer. However, since tumors originate from normal cells and evolve within the context of self-tissues, the immune mechanisms that prevent the autoimmune attack of normal tissues function in parallel to restrict anti-tumor immunity. In particular, the purging of autoreactive T cells and the development of immune-suppressive regulatory T cells (Tregs) are thought to be major barriers impeding anti-tumor immune responses. Here, we discuss current understanding regarding the antigens recognized by tumor-infiltrating T-cell populations, the mechanisms that shape the repertoire of these cells, and the role of the transcription factor autoimmune regulator (Aire) in these processes. Further elucidation of these principles is likely to be critical for optimizing emerging cancer immunotherapies, and for the rational design of novel therapies exhibiting robust anti-tumor activity with limited toxicity.

    Other authors
    See publication
  • Organ-specific regulatory T cells of thymic origin are expanded in murine prostate tumors.

    OncoImmunology

    Little is known about the relative contributions of self-specific regulatory T cells (Tregs) of thymic origin and induced Tregs generated extrathymically to the pool of tumor-infiltrating Tregs. We have recently demonstrated that thymic-derived Tregs reactive to a prostate-associated self antigen are highly and recurrently enriched within oncogene-driven murine prostate cancers.

    Other authors
    See publication
  • Aire-dependent thymic development of tumor-associated regulatory T cells.

    Science

    Despite considerable interest in the modulation of tumor-associated Foxp3+ regulatory T cells (Tregs) for therapeutic benefit, little is known about the developmental origins of these cells and the nature of the antigens that they recognize. We identified an endogenous population of antigen-specific Tregs (termed MJ23 Tregs) found recurrently enriched in the tumors of mice with oncogene-driven prostate cancer. MJ23 Tregs were not reactive to a tumor-specific antigen but instead recognized a…

    Despite considerable interest in the modulation of tumor-associated Foxp3+ regulatory T cells (Tregs) for therapeutic benefit, little is known about the developmental origins of these cells and the nature of the antigens that they recognize. We identified an endogenous population of antigen-specific Tregs (termed MJ23 Tregs) found recurrently enriched in the tumors of mice with oncogene-driven prostate cancer. MJ23 Tregs were not reactive to a tumor-specific antigen but instead recognized a prostate-associated antigen that was present in tumor-free mice. MJ23 Tregs underwent autoimmune regulator (Aire)–dependent thymic development in both male and female mice. Thus, Aire-mediated expression of peripheral tissue antigens drives the thymic development of a subset of organ-specific Tregs, which are likely coopted by tumors developing within the associated organ.

    Other authors
    See publication
  • Basic principles of tumor-associated regulatory T cell biology.

    Trends in Immunology

    Due to the critical role of forkhead box (Fox)p3+ regulatory T cells (Tregs) in the regulation of immunity and the enrichment of Tregs within many human tumors, several emerging therapeutic strategies for cancer involve the depletion or modulation of Tregs, with the aim of eliciting enhanced antitumor immune responses. Here, we review recent advances in understanding of the fundamental biology of Tregs, and discuss the implications of these findings for current models of tumor-associated Treg…

    Due to the critical role of forkhead box (Fox)p3+ regulatory T cells (Tregs) in the regulation of immunity and the enrichment of Tregs within many human tumors, several emerging therapeutic strategies for cancer involve the depletion or modulation of Tregs, with the aim of eliciting enhanced antitumor immune responses. Here, we review recent advances in understanding of the fundamental biology of Tregs, and discuss the implications of these findings for current models of tumor-associated Treg biology. In particular, we discuss the context-dependent functional diversity of Tregs, the developmental origins of these cells, and the nature of the antigens that they recognize within the tumor environment. In addition, we highlight critical areas of focus for future research.

    Other authors
    See publication
  • Characterization of Cytokeratin 8 in Cancer.

    Undergraduate Research Journal

Courses

  • Bio-statistics

    -

  • Biochemistry

    -

  • Biology

    -

  • Biotech and Gentic Engineering

    -

  • Cancer Biology: Intro to Cancer Biology

    -

  • Cancer Biology: Molecular Mechanisms of Cancer

    -

  • Cancer Biology: Signal Transduction and Model Organisms

    -

  • Cancer Immunology

    -

  • Cell Biology

    -

  • Chemistry I-III

    -

  • Current Topics in Biotechnology

    -

  • Experimental Cancer Biology

    -

  • Experimental Molecular Biology

    -

  • Foundations of Biological Imaging

    -

  • Fundamentals of Molecular Biology

    -

  • General Microbiology

    -

  • Grant Writing and Lab Mouse Techniques

    -

  • Human Physiology

    -

  • Immunopathology

    -

  • Intro to Clincal Trials

    -

  • Methods in Biotechnology

    -

  • Microbial Metabolism

    -

  • Molecular Biology I-III

    -

  • Molecular Biotechnology

    -

  • Molecular Immunology

    -

  • Nanobiotechnology

    -

  • Organic Chemistry I & II

    -

  • Physics I & II

    -

  • Principles of Statistics

    -

  • Protein Fundamentals

    -

  • Quantitative Biological Methods

    -

  • Team Translational Project I-III

    -

Projects

  • Characterization of Tumor-associated Treg Development, Specificity and Function.

    - Present

    The overall objectives of my dissertation research are to determine the development, antigenic specificity and the functional role of tumor-associated Tregs in the context of prostate cancer. Building off of previous studies in the lab which had identified several Treg-specific T cell receptors (TCRs) which were recurrently enriched in TRAMP prostate tumors, I began investigating the development and antigenic specificities of these cells. These studies, which were carried out in close…

    The overall objectives of my dissertation research are to determine the development, antigenic specificity and the functional role of tumor-associated Tregs in the context of prostate cancer. Building off of previous studies in the lab which had identified several Treg-specific T cell receptors (TCRs) which were recurrently enriched in TRAMP prostate tumors, I began investigating the development and antigenic specificities of these cells. These studies, which were carried out in close collaboration with Dr. Sven Malchow, a postdoctoral fellow in the lab, led to several novel findings which were published in Science, the acceptance of abstracts to allow me to present our data at both the AACR and AAI annual meetings, and an AAI Trainee Poster Award. Perhaps one of the most impactful findings was that two of the most highly enriched Treg specificities found in TRAMP prostate tumors were dependent on the expression of peripheral tissue antigens in the thymus by the transcriptional regulator Aire for their development. While Aire had been previously shown to play a critical role in the negative selection of autoreactive T cells against tissue specific antigens, our data challenged current paradigms by showing that it also played a role in Treg development in the thymus. Our data also suggest a potential “division of labor” between Aire-dependent and Aire-independent Tregs in the regulation of autoimmunity to peripheral organs and potentially tumor immune responses, raising several critical areas for investigation of this novel putative Treg subset. Therefore it is the objective of this proposal to elucidate the functional roles of Aire-dependent Tregs in maintaining organ-specific immune tolerance and determine their functional impact on prostate cancer progression.

  • Breast Cancer Start-Up Challenge

    -

    Core Team member in business plan competition aimed at commercializing technologies held by the National Cancer Institute.
    --------------------------------------------
    The Avon Foundation, The Center for Advancing Innovation, and the National Institutes of Health National Cancer Institute have partnered to create the first ever business plan and start-up "Challenge" featuring inventions conceived and developed by scientists at the National Cancer Institute and Avon Foundation grantees to…

    Core Team member in business plan competition aimed at commercializing technologies held by the National Cancer Institute.
    --------------------------------------------
    The Avon Foundation, The Center for Advancing Innovation, and the National Institutes of Health National Cancer Institute have partnered to create the first ever business plan and start-up "Challenge" featuring inventions conceived and developed by scientists at the National Cancer Institute and Avon Foundation grantees to accelerate commercialization in support of high-growth businesses that spur entrepreneurship

    Other creators
    See project
  • The Effects of Chemokine Expression on Melanoma Growth Kinetics and Immune Cell Infiltrates

    -

    During my second rotational project in the laboratory of Dr. Gajewski I further expanded my expertise in the field of tumor immunology and gained experience utilizing transplantable models of cancer in mice. Previous studies in the lab in which the chemokine expression profiles of human melanoma biopsies were assayed had identified a panel of chemokines exhibiting increased expression correlated with increases in T cell infiltration within the tumor lesions. To elucidate the role of…

    During my second rotational project in the laboratory of Dr. Gajewski I further expanded my expertise in the field of tumor immunology and gained experience utilizing transplantable models of cancer in mice. Previous studies in the lab in which the chemokine expression profiles of human melanoma biopsies were assayed had identified a panel of chemokines exhibiting increased expression correlated with increases in T cell infiltration within the tumor lesions. To elucidate the role of tumor-derived chemokines in the regulation of anti-tumor immune responses, the Gajewski lab generated several versions of the transplantable mouse melanoma cell line B16 which expressed the murine homologs of the chemokines identified. It was thus the objective of my rotational project to analyze the effects of each chemokine on tumor growth, immune cell infiltrates and T cell activation/priming against a model antigen co-expressed by B16 tumor cells. This project allowed me to gain new expertise in cancer biology and substantially increased my technical expertise in multi-color flow cytometry.

    Techniques Gained: Cell culture, transplantable tumor models, tumor growth analysis, tumor immune cell infiltrate harvest and analysis, IFNγ Elispot assay, advanced flow cytometry and ELISA

  • The Utilization of Extracellular Gaussian Luciferase (extGLuc) to Track Rare Populations of T cells In Vivo

    -

    During my first rotational project as a graduate student in the Cancer Biology program at the University of Chicago, I continued to build upon my laboratory expertise and was first introduced to the field of Tumor Immunology. Dr. Schreiber’s laboratory is interested in understanding the dynamics of T cell responses against tumor antigens. One tool the lab wished to utilize in order to track in vivo T cell responses in real time was bioluminescence. However, the sensitivity of commonly used…

    During my first rotational project as a graduate student in the Cancer Biology program at the University of Chicago, I continued to build upon my laboratory expertise and was first introduced to the field of Tumor Immunology. Dr. Schreiber’s laboratory is interested in understanding the dynamics of T cell responses against tumor antigens. One tool the lab wished to utilize in order to track in vivo T cell responses in real time was bioluminescence. However, the sensitivity of commonly used Firefly and Renilla luciferases is too low to detect tumor-specific T cell populations in vivo. Therefore, it was the objective of my research project to incorporate a novel luciferase (extracellular Gaussian luciferase), which showed more than 200-fold increased signal, into the current constructs utilized by the lab in order to visualize rare populations of T cells responding to tumor antigens. Due to several technical challenges which arose during my rotational project, I was able to master several critical laboratory techniques and gain critical problem solving skills which would be extremely helpful in future projects. Additionally, throughout my rotation in the Schreiber lab I was able to gain further expertise in the field of immunology, further instilling my interests in the tumor immunology field.

    Techniques Gained: Retroviral vector generation, retroviral transduction, primary T cell transduction, flow cytometry, mouse dissection and bioluminescence imaging

  • A Model System for Analysis of a Novel Cancer Target with Diagnostic and Therapeutic Potential: Cytokeratin 8

    -

    I was first introduced to biomedical research as an undergraduate researcher in Dr. Mark T. Muller’s lab. Choosing to take on an independent research project which had not yet been established in the lab gave me the opportunity to formally design and carry out a study from conceptualization to publication. My project originated from previously published data from a collaborating lab which showed that cancer patients having solid tumors of a variety of tissues types (breast, head and neck…

    I was first introduced to biomedical research as an undergraduate researcher in Dr. Mark T. Muller’s lab. Choosing to take on an independent research project which had not yet been established in the lab gave me the opportunity to formally design and carry out a study from conceptualization to publication. My project originated from previously published data from a collaborating lab which showed that cancer patients having solid tumors of a variety of tissues types (breast, head and neck, prostate, etc.) had increased titers of antibodies against the cytoskeletal protein Cytokeratin 8. It was thus my project to understand the dynamics of Cytokeratin 8 utilizing several cancer cell lines and to recapitulate and optimize the previously shown enzyme linked immunosorbent assay (ELISA) diagnostic for increased titers of anti-cytokeratin 8 antibodies in cancer patient’s sera. Throughout the research process I applied for and successfully received over $11,000 in funding through both internal mechanisms in the University and through the American Cancer Society. Additionally, my project resulted in an “Honors in The Major” Thesis and a first author publication in the Undergraduate Research Journal. After graduating, my project was taken on by a collaborating scientist at the MD Anderson Cancer Center of Orlando.

    Techniques Gained: Molecular cloning, immunofluorescence, confocal microscopy, basic flow cytometry and ELISA based screen design and calibration

Honors & Awards

  • University of Chicago Cancer Research Foundation Elaine Ehrman Award

    University of Chicago Cancer Research Foundation

  • Ruth L. Kirschstein National Research Service Award NIH F31

    National Cancer Institute (via National Institutes of Health)

  • AAI Trainee Poster Award

    American Association of Immunologists

  • NIH Cancer Biology Training Grant

    National Institutes of Health

  • American Cancer Society Fellowship

    American Cancer Society

  • Honors in the Major

    University of Central Florida

  • Research and Mentoring Program (RAMP) Grant

    University of Central Florida

  • Sherwood Blue Scholarship

    Theta Chi Fraternity International

  • Student-Mentor Academic Research Teams (SMART) Grant

    University of Central Florida

  • UCF Alumni Association President's Scholarship

    University of Central Florida Alumni Association

  • Lead Scholars Award

    University of Central Florida Lead Scholars Organization

  • Order of Omega (Greek Honors Society) Inductee

    University of Central Florida Order of Omega

  • Bright Futures Scholarship

    State of Florida

More activity by Daniel

View Daniel’s full profile

  • See who you know in common
  • Get introduced
  • Contact Daniel directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Add new skills with these courses